- Advertisement -
A Brazilian trial evaluating the safety and efficacy of low-dose THC-CBD cannabinoid extract in the treatment of patients with Alzheimer’s Disease associated dementia has proved promising.
A neurodegenerative disease, Alzheimer’s affects many millions of people around the world; and as we live…
